232 related articles for article (PubMed ID: 24457967)
1. A cell-penetrating peptide based on the interaction between c-Src and connexin43 reverses glioma stem cell phenotype.
Gangoso E; Thirant C; Chneiweiss H; Medina JM; Tabernero A
Cell Death Dis; 2014 Jan; 5(1):e1023. PubMed ID: 24457967
[TBL] [Abstract][Full Text] [Related]
2. Connexin43 recruits PTEN and Csk to inhibit c-Src activity in glioma cells and astrocytes.
González-Sánchez A; Jaraíz-Rodríguez M; Domínguez-Prieto M; Herrero-González S; Medina JM; Tabernero A
Oncotarget; 2016 Aug; 7(31):49819-49833. PubMed ID: 27391443
[TBL] [Abstract][Full Text] [Related]
3. A Short Region of Connexin43 Reduces Human Glioma Stem Cell Migration, Invasion, and Survival through Src, PTEN, and FAK.
Jaraíz-Rodríguez M; Tabernero MD; González-Tablas M; Otero A; Orfao A; Medina JM; Tabernero A
Stem Cell Reports; 2017 Aug; 9(2):451-463. PubMed ID: 28712848
[TBL] [Abstract][Full Text] [Related]
4. Dual inhibition of Src and PLK1 regulate stemness and induce apoptosis through Notch1-SOX2 signaling in EGFRvIII positive glioma stem cells (GSCs).
Li X; Tao Z; Wang H; Deng Z; Zhou Y; Du Z
Exp Cell Res; 2020 Nov; 396(1):112261. PubMed ID: 32896567
[TBL] [Abstract][Full Text] [Related]
5. Connexin43 Region 266-283, via Src Inhibition, Reduces Neural Progenitor Cell Proliferation Promoted by EGF and FGF-2 and Increases Astrocytic Differentiation.
Talaverón R; Matarredona ER; Herrera A; Medina JM; Tabernero A
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238452
[TBL] [Abstract][Full Text] [Related]
6. The role of connexin43-Src interaction in astrocytomas: A molecular puzzle.
Tabernero A; Gangoso E; Jaraíz-Rodríguez M; Medina JM
Neuroscience; 2016 May; 323():183-94. PubMed ID: 25711938
[TBL] [Abstract][Full Text] [Related]
7. Connexin 43 reverses malignant phenotypes of glioma stem cells by modulating E-cadherin.
Yu SC; Xiao HL; Jiang XF; Wang QL; Li Y; Yang XJ; Ping YF; Duan JJ; Jiang JY; Ye XZ; Xu SL; Xin YH; Yao XH; Chen JH; Chu WH; Sun W; Wang B; Wang JM; Zhang X; Bian XW
Stem Cells; 2012 Feb; 30(2):108-20. PubMed ID: 22131169
[TBL] [Abstract][Full Text] [Related]
8. Biotinylated Cell-penetrating Peptides to Study Intracellular Protein-protein Interactions.
Jaraíz-Rodríguez M; González-Sánchez A; García-Vicente L; Medina JM; Tabernero A
J Vis Exp; 2017 Dec; (130):. PubMed ID: 29286477
[TBL] [Abstract][Full Text] [Related]
9. HIF-1 and c-Src mediate increased glucose uptake induced by endothelin-1 and connexin43 in astrocytes.
Valle-Casuso JC; González-Sánchez A; Medina JM; Tabernero A
PLoS One; 2012; 7(2):e32448. PubMed ID: 22384254
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of connexin43 potentiates noradrenaline-induced expression of brain-derived neurotrophic factor in primary cultured cortical astrocytes.
Morioka N; Kondo S; Harada N; Takimoto T; Tokunaga N; Nakamura Y; Hisaoka-Nakashima K; Nakata Y
J Cell Physiol; 2021 Oct; 236(10):6777-6792. PubMed ID: 33665818
[TBL] [Abstract][Full Text] [Related]
11. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ID1-BMPR2 Intrinsic Signaling Sensitizes Glioma Stem Cells to Differentiation Therapy.
Jin X; Jin X; Kim LJY; Dixit D; Jeon HY; Kim EJ; Kim JK; Lee SY; Yin J; Rich JN; Kim H
Clin Cancer Res; 2018 Jan; 24(2):383-394. PubMed ID: 29208670
[No Abstract] [Full Text] [Related]
13. Connexin 43 enhances the adhesivity and mediates the invasion of malignant glioma cells.
Lin JH; Takano T; Cotrina ML; Arcuino G; Kang J; Liu S; Gao Q; Jiang L; Li F; Lichtenberg-Frate H; Haubrich S; Willecke K; Goldman SA; Nedergaard M
J Neurosci; 2002 Jun; 22(11):4302-11. PubMed ID: 12040035
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of Cx43 residue Y313 by Src contributes to blocking the interaction with Drebrin and disassembling gap junctions.
Zheng L; Li H; Cannon A; Trease AJ; Spagnol G; Zheng H; Radio S; Patel K; Batra S; Sorgen PL
J Mol Cell Cardiol; 2019 Jan; 126():36-49. PubMed ID: 30448479
[TBL] [Abstract][Full Text] [Related]
15. EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer.
Singh S; Trevino J; Bora-Singhal N; Coppola D; Haura E; Altiok S; Chellappan SP
Mol Cancer; 2012 Sep; 11():73. PubMed ID: 23009336
[TBL] [Abstract][Full Text] [Related]
16. Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43
Pelaz SG; Jaraíz-Rodríguez M; Álvarez-Vázquez A; Talaverón R; García-Vicente L; Flores-Hernández R; Gómez de Cedrón M; Tabernero M; Ramírez de Molina A; Lillo C; Medina JM; Tabernero A
EBioMedicine; 2020 Dec; 62():103134. PubMed ID: 33254027
[TBL] [Abstract][Full Text] [Related]
17. Increased invasive capacity of connexin43-overexpressing malignant glioma cells.
Zhang W; Nwagwu C; Le DM; Yong VW; Song H; Couldwell WT
J Neurosurg; 2003 Dec; 99(6):1039-46. PubMed ID: 14705732
[TBL] [Abstract][Full Text] [Related]
18. Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo.
Jaraíz-Rodríguez M; Talaverón R; García-Vicente L; Pelaz SG; Domínguez-Prieto M; Álvarez-Vázquez A; Flores-Hernández R; Sin WC; Bechberger J; Medina JM; Naus CC; Tabernero A
Neuro Oncol; 2020 Apr; 22(4):493-504. PubMed ID: 31883012
[TBL] [Abstract][Full Text] [Related]
19. SHP2 regulates proliferation and tumorigenicity of glioma stem cells.
Roccograndi L; Binder ZA; Zhang L; Aceto N; Zhang Z; Bentires-Alj M; Nakano I; Dahmane N; O'Rourke DM
J Neurooncol; 2017 Dec; 135(3):487-496. PubMed ID: 28852935
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C
Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
